Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,757.84
+1,637.32(+3.33%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Voyager Therapeutics, Inc. (VYGR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

8.81

+0.28

(+3.28%)

At close: 04:00PM EDT

8.77

-0.04

(-0.45%)

After hours:

05:07PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	479.16M
Enterprise value	268.58M
Trailing P/E	2.97
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.57
Price/book (mrq)	2.03
Enterprise value/revenue	1.07
Enterprise value/EBITDA	2.12

Trading information

Stock price history

Beta (5Y monthly)	0.95
52-week change ³	2.65%
S&P500 52-week change ³	22.38%
52-week high ³	14.34
52-week low ³	6.06
50-day moving average ³	8.81
200-day moving average ³	8.19

Share statistics

Avg vol (3-month) ³	658.99k
Avg vol (10-day) ³	450.73k
Shares outstanding ⁵	54.39M
Implied shares outstanding ⁶	54.39M
Float ⁸	36.96M
% held by insiders ¹	16.91%
% held by institutions ¹	49.37%
Shares short (15 Apr 2024) ⁴	3.46M
Short ratio (15 Apr 2024) ⁴	4.08
Short % of float (15 Apr 2024) ⁴	7.60%
Short % of shares outstanding (15 Apr 2024) ⁴	6.37%
Shares short (prior month 15 Mar 2024) ⁴	2.31M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	52.93%
Operating margin (ttm)	60.03%

Management effectiveness

Return on assets (ttm)	29.87%
Return on equity (ttm)	89.61%

Income statement

Revenue (ttm)	250.01M
Revenue per share (ttm)	5.81
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	126.45M
Net income avi to common (ttm)	132.33M
Diluted EPS (ttm)	2.97
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	230.88M
Total cash per share (mrq)	4.25
Total debt (mrq)	20.29M
Total debt/equity (mrq)	8.59%
Current ratio (mrq)	4.96
Book value per share (mrq)	5.37

Cash flow statement

Operating cash flow (ttm)	77.92M
Levered free cash flow (ttm)	-3.01M